M&A Deal Summary |
|
---|---|
Date | 2007-07-11 |
Target | Qualis |
Sector | Medical Products |
Buyer(s) | Perrigo Company |
Deal Type | Add-on Acquisition |
Deal Value | 12M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1887 |
Sector | Life Science |
Employees | 9,140 |
Revenue | 4.7B USD (2023) |
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 5 of 31 |
Sector (Medical Products) | 3 of 10 |
Type (Add-on Acquisition) | 4 of 23 |
State (Iowa) | 1 of 1 |
Country (United States) | 2 of 18 |
Year (2007) | 1 of 1 |
Size (of disclosed) | 23 of 23 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-03-15 |
Agis Industries
Bnei Brak, Israel Agis Industries (1983) Ltd. develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients, novel dermatological products and consumer products. Agis is the second largest pharmaceutical company in Israel. The Company manufactures in Israel, the United States and Germany |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-01-09 |
Galpharm Healthcare
Barnsley, United Kingdom Galpharm Healthcare Ltd. it the supplier of over-the-counter (OTC) store brand pharmaceutical products sold by super markets, drug stores and pharmacies in the U.K |
Buy | $86M |